Poorer nations face dire health risks from limited antibiotic access, fueling preventable deaths and antimicrobial resistance. In Africa and South Asia, where AMR claims countless lives, barriers like weak supply chains and high costs block access to essential drugs. Equitable pricing, technology transfers, and data-driven strategies are vital to ensure these countries can combat infections effectively.
While limited antibiotic access in poorer nations fuels AMR and preventable deaths, overuse through unregulated sales and self-medication is a greater driver of resistance. Weak regulations and low awareness in LMICs promote the misuse of antibiotics, necessitating robust stewardship, education, and diagnostics to curb AMR effectively.